Targeting Interleukin-13 with Tralokinumab Attenuates Lung Fibrosis and Epithelial Damage in a Humanized SCID Idiopathic Pulmonary Fibrosis Model

The aberrant fibrotic and repair responses in the lung are major hallmarks of idiopathic pulmonary fibrosis (IPF). Numerous antifibrotic strategies have been used in the clinic with limited success, raising the possibility that an effective therapeutic strategy in this disease must inhibit fibrosis...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Murray, Lynne A., Zhang, Huilan, Oak, Sameer R., Coelho, Ana Lucia, Herath, Athula, Flaherty, Kevin R., Lee, Joyce, Bell, Matt, Knight, Darryl A., Martinez, Fernando J., Sleeman, Matthew A., Herzog, Erica L., Hogaboam, Cory M.
Formato: Artigo
Idioma:Inglês
Publicado: American Thoracic Society 2014
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4068948/
https://ncbi.nlm.nih.gov/pubmed/24325475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1165/rcmb.2013-0342OC
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares